Akeso's ivonescimab reduces death risk by 34% in phase three lung cancer trial, the first Chinese drug selected for ASCO's plenary in 61 years, targeting a $20B market.

Series A financing co-led by Balyasny Asset Management, venBio, and Janus Henderson InvestorsRugonersen, a potentially ...

Following a historic slump in cotton harvest, the Ministry of National Food Security and Research has drawn up a draft three-year National Agricultural Biotechnology Policy (NABP) - 2025 aimed at ...

BioMedWire Editorial Coverage: As oncology drug-development costs continue climbing and regulatory pathways become increasingly complex, biotechnology companies are placing renewed emphasis on ...

Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, Strengthening LIXTE’s Strategic Expansion into AI Energy Infrastr ...

The academic reputation of Amity University Punjab continues to grow, driven by numerous international accreditations and ...

This clinical-stage biotech develops precision genetic medicines for neurological and hepatic disorders via its PRISM platform.

The deep ocean, encompassing depths greater than 200 meters, represents Earth’s largest and least explored biome. It sustains immense microbial diversity ...

Emphasizes Importance of Experienced Biotech Leadership as Vaxart AdvancesClinical and Strategic Priorities with Multiple Value-Creating ...

When life gives you lemons, you make pillows. That’s just the case for a Massachusetts entrepreneur who turned a canceled birthday party into a successful business. And her slogan is: "Forget diamonds ...

Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company focused on cannabinoid biotechnology, ...

Biond Biologics and Guangzhou-Israel Biotechnology Fund (GIBF) Announce Strategic Investment and Joint Venture to Advance First-in-Class Oncology Programs in China ...